In addition, 8 cases assigned to the MDS-SF3B1 entity according to WHO belong to MDS, NOS according to ICC due to presence of RUNX1 mutations (n = 7) or SF3B1 VAF < 10% (n = 1). This evidence concerns the gene RUNX1 and intrahepatic cholangiocarcinoma.